Chain Drug Review - Caraco gets clearance
Caraco Pharmaceutical Laboratories Ltd. has received tentative approval for generic Coreg tablets. The product (carvedilol) is for teating mild to severe heart failure of ischemic or cardiomyopathic origin.
Related Results
Trial data added to coreg labelNew indications for once-daily CoregFlamel Technologies Welcomes FDA Approval of COREG CR™Flamel Technologies Welcomes Nationwide Availability of COREG CR™New & approved: Coreg biotronik home monitoring system
COPYRIGHT 2006 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
